Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Iron overload in myelodysplastic syndromes: diagnosis and management.

    ... (RBC) transfusions for symptomatic management of refractory anemia . Iron overload ensues when the iron acquired ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Tea consumption reduces the risk of de novo myelodysplastic syndromes

    ... The inverse association existed in both genders, in the refractory anemia with excessive blasts subtype, in ... System lower and higher risk groups, but not in the refractory cytopenia with multilineage dysplasia subtype. The study ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*.

    ... study, patients with higher-risk MDS (FAB-defined refractory anemia with excess blasts (RAEB), RAEB in ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.

    ... to different World Health Organization subtypes, refractory anemia with ringed sideroblasts patients had the lowest hepcidin levels (105.40 ± 5.13 ng/ml), while refractory anemia with excess blasts -1 had the highest levels (335.71 ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

    ... from phagocytosis in vitro. However, in the high-risk refractory anemia with excess blasts (RAEB) stages of MDS, ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

    ... severity of AA and to efficiently treat patients with refractory and relapsed AA. Immune-mediated AA was reproduced in animals, ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. Diagnosis and management of aplastic anemia

    ... agents provide multiple alternatives for treating refractory or relapsed patients. Best practices in this regard are not yet ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Immunosuppressive therapy for transplant-ineligible aplastic anemia patients

    ... in first-line treatment and management of relapsing and refractory patients with an emphasis on adult patients. Some promising new ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA)

    ... untreated or in remission than in patients with refractory disease. Allogeneic HSCT leads to prolonged survival in close ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. Management of acquired aplastic anemia in children

    ... agents provide multiple alternatives for treating refractory or relapsed patients. Regardless of the type of therapeutic ...

    Research Article last updated 07/20/2018 - 5:15pm.